LKLoganathan Karthik

Loganathan Karthik

*This is an algorithmically generated author record based on publicly available information.

Loganathan Karthik has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Editorial: Metabolic engineering and synthetic biology for sustainable microbial cell factories

    by Mugesh Sankaranarayanan, Karthik Loganathan, Lorenzo Pasotti

    Sustainable synthesis of chemicals, pharmaceuticals, fuels, and other value-added products has become an urgent priority among major industrial manufacturing sectors. Microorganisms have been responsible for breakthroughs in the field of medicine, industry, and biosustainability for thousands of years. Microbial cells serve as ideal factories for the sustainable synthesis of key economic drivers for nations. Advancements have evolved from optimizing biosynthesis capability in wild-type/natural microbial hosts to rational design and harnessing engineered microbial cell factories. Metabolic Engineering and Synthetic Biology have emerged as central disciplines of biomanufacturing, enabling the precise rewiring of metabolic pathways and engineering of microbial cells to boost titre, rate, and yield. The integration of genomic data mining, synthetic biology, and metabolic engineering has made it possible to utilize microbial systems as tools that can be programmed to produce highquality bioactive molecules. Such an approach plays a vital role in tackling the growing problems associated with resistance to antibiotics, resource depletion, pollution and sustainable manufacturing practices. A large proportion of the biosynthesis potential of microbes is unknown, and current production processes are often limited by their capacity in terms of productivity, efficiency, and scaling. Current advances in biotechnology involve the use of new technologies like multi-omics methods, strain engineering, and innovative bioprocessing technologies to unlock untapped metabolic potential and increase functionality. The translational impact of microbiology research has also increased, including both bioprospecting of bioactive gene clusters and metabolic engineering. Though this domain has paved an avenue for next-generation biomanufacturing, it comes with its own challenges, such as metabolic bottlenecks, limited host compatibility, non-availability of genetic toolkits for non-model organisms, and lack of high-throughput screening of mutants, etc. However, current trends have seen a rapid rise in novel tools, techniques, and strategies in the field of metabolic engineering and synthetic biology. As part of this trend, this research topic contains articles addressing various aspects of microbial biotechnology, including the discovery of new bioactive compounds, metabolic engineering, environmental management, and pharmaceutical applications.The purpose of the research topic was to examine the emerging field of microorganisms as flexible tools in the search for bioactive substances, biomanufacturing processes, environmental purification technologies, and new therapies. This research topic intends to compile studies focused on the use of genome mining, metabolic engineering, microbial cell factories, and applied microbiology to explore a modern microbiological approach to addressing important world problems. In total, 10 papers, among which original and review articles were compiled to highlight recent progress in the study of the biosynthetic potential of microorganisms, optimization of metabolism, and application of microbial capabilities in practice.The current status of genome mining is such that there have been discoveries of previously unknown, cryptic biosynthetic gene clusters (BGCs) that produce metabolites with a wide range of structural diversity and biological activity. In this regard, Christopher et al. have addressed microbial genomes as the major source of unexplored biosynthetic capabilities. As such, BGCs within Streptomyces sp. were analyzed using in silico tools for subsequent identification and confirmation of the activity of bioactive compounds that may serve as a promising base for next-generation antimicrobials. In line with this viewpoint, investigations carried out among endophytic and marine microbes show their potential as rich producers of novel secondary metabolites due to the particular environment they occupy.Aside from discoveries, there are several advancements associated with the rational design and engineering of microbial cells for efficient biosynthesis of valuable chemicals. In one study, Ma et al. showed an interesting method of metabolic engineering and how the modification of tRNA m7G can help reprogram cellular metabolism to improve terpenoid biosynthesis in yeasts. Meanwhile, in a review conducted by Li et al. the synthesis of caffeic acid through heterologous production was described. This review highlighted strategies such as pathway optimization and host selection techniques to efficiently increase titers in microbes. In another study, Lin et al. improved microbial biosynthesis by designing B. subtilis that can effectively alter the molecular weight of the polymer to increase the versatility of poly-γ-glutamic acid in industries.Microbial Biotechnology can also be recognized as one of the most effective tools to solve environmental problems, along with creating a bioeconomy cycle. The advances in microbial and enzymatic degradation of polyethylene terephthalate (PET) and the contribution of enzyme engineering, synthetic biology, and microbial communities in the process of depolymerization and recycling of plastics into useful products have been reviewed by Liu et al. Furthermore, the oleaginous strains of Streptomyces were found to be able to transform the sewage sludge into biolipids, which, in turn, were used to produce biofuels. Thus, the mentioned findings prove that the technology of microbial biotechnology provides an opportunity not only to cope with environmental problems but also to use the available resources for generating renewable energy. Furthermore, there is evidence that the importance of using microorganisms for applications related to human health is growing, including those in the fields of biomedicine and biotechnology. Wang et al. showed that engineered microbes could serve as delivery vectors for immunotoxins for targeted cancer...

  • Open Access

    Glycemic Control Efficacy of ‘Avaram Amrit’ in Type 2 Diabetes Mellitus: A 12-Week Open-Label Clinical Trial

    by Vishnu Kirthi Arivarasan, Ramapriya Karthik, Kiran Gangarapu, Sangeethalakshmi Suman, Sathyarajeswaran P, Shree Devi M.S.

    Background: Avaram Amrit, derived from a traditional medicinal plant, has shown potential in diabetes management. This study aimed to evaluate its clinical efficacy in glycemic control. Methods: A 12-week, open-label clinical trial was conducted with 9 type 2 diabetes patients. Participants received Avaram Amrit extract daily. Fasting and postprandial glucose levels were measured bi-weekly, with HbA1c assessed at baseline and week 12. Results: Fasting glucose levels decreased significantly from 252.54 ± 71.99 mg/dL at baseline to 195.50 ± 55.01 mg/dL at week 12 (p<0.001), representing a 22.6% reduction. Mean HbA1c decreased by 1.25 percentage points. Postprandial glucose levels showed consistent improvement across the study period. A strong positive correlation was observed between initial HbA1c and fasting glucose (r=0.89). Conclusion: Avaram Amrit demonstrated significant improvement in glycemic control over 12 weeks. The consistent decrease in both short-term (glucose levels) and long-term (HbA1c) measures indicates a positive response to the intervention. While promising, larger randomized controlled trials are necessary to confirm these findings and establish Avaram Amrit's role in diabetes management.

  • Current approaches in CRISPR-Cas systems for diabetes

    by Vishnu Kirthi Arivarasan, Diksha Diwakar, Neethu Kamarudheen, Karthik Loganathan


  • Open Access

    Draft genome sequences of the strains isolated from estuary sediments

    by Rameshkumar Dhanakoti, Vijayanand Dhanakoti, Karthik Loganathan, Mohandass Swathanthiram

    Draft genome sequences of four strains of the Bacillaceae were generated using nanopore technology. The size of the genome ranges from 4.2 to 4.4 Mb. This study aims to enhance our understanding of the diversity of probable probiotic strains, their metabolic activities, and their safety in real-world applications.

  • CRISPR ERA: Current Applications and Future Perspectives on Actinobacteria

    by Loganathan Karthik, Vishnu Kirthi Arivarasan, Mahendran Ruckmani Vignesh, Palakshi Anitha


  • Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria

    by Gangarapu Kiran, Loganathan Karthik, Gouthami Thumma, Arivarasan Vishnukirthi


  • Top Cited Papers
    Open Access

    In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein

    by Gangarapu Kiran, L. Karthik, M.S. Shree Devi, P. Sathiyarajeswaran, K. Kanakavalli, K.M. Kumar, D. Ramesh Kumar


  • ‘Synergistic-Cidal’ Effect of Amoxicillin Conjugated Silver Nanoparticles Against Escherichia coli

    by Vishnu Kirthi Arivarasan, Karthik Loganathan, Jayachandran Venkatesan, Atul Changdev Chaskar


  • Modern Approach in Lectin-Based Nanomedicine

    by Arivarasan Vishnu Kirthi, Loganathan Karthik, Babu Gajendran